about
L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: Involvement of src family kinasesFunctions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease.Oxidized dNTPs and the OGG1 and MUTYH DNA glycosylases combine to induce CAG/CTG repeat instability.Stimulation of adenosine A2A receptors reduces intracellular cholesterol accumulation and rescues mitochondrial abnormalities in human neural cell models of Niemann-Pick C1.Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease.Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington's disease mice.Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum.BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved.Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum.Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons.Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease.Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects.Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus.Neuroprotective effects of thymosin beta4 in experimental models of excitotoxicity.Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism.Sperm endogenous reverse transcriptase as mediator of new genetic information.Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease.Complex behavioral and synaptic effects of dietary branched chain amino acids in a mouse model of amyotrophic lateral sclerosisNeuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia
P50
Q28568299-4DF2C9FA-CAAB-45F9-A8C8-85E926FEDA23Q36736573-6D0854EB-5183-47AE-968E-B9ED78D0DFFFQ37021524-F16BBF5C-3E5E-4596-BE1E-B7CCA80D7803Q38814748-DF4E81F9-D58E-46CE-BE5D-2C1424226F88Q39959489-277BE118-65CD-44AE-B561-040F497EE20CQ42479637-863D540A-055A-42C3-8396-FFCDE9826C8AQ42514510-E9A9B429-4238-4741-BB9D-1773FEDF0C55Q43170602-9B3A8875-BC19-4112-8188-14ECDC83D986Q43266904-0DFBCDD1-0C55-4569-86DA-AFC4E2D77579Q44930729-028575AF-D4E8-43E7-AB97-AF9B9ECF55D7Q44937017-E81C39D6-E1EC-44E2-A307-38441C8CF223Q45018906-213C6E23-A613-42D0-A47C-E2F4E77C8C6FQ45291563-92277D04-49BD-40C7-A739-31E65929E5BDQ45301173-54F57382-DF08-4327-9BAE-B6FD444FEA18Q45302088-D673EAB7-1455-4AF8-BAEA-14BE44231104Q45304336-3AA0F0F5-AC31-4BD6-A09F-45132C29EDC9Q45305730-F75E8AD1-B470-4601-8B95-73C2EE850660Q45306032-104FE85A-8E36-488A-8949-999780A78C00Q45922072-FC187376-8530-4D56-BD6D-6348AD156105Q45924904-24B130C9-8501-42BF-A74E-78DFF17306D6Q46478889-82ED4358-8A81-455C-9268-66EAFA44AAC7Q46791403-84CFC4F3-863A-4B2F-802A-E28A046D0EA1Q46898637-71D549E9-958A-4593-B9FB-0580A8300C73Q46942207-A1569718-A55A-43BE-9AE4-DFB2FF27EDB5Q48238510-CFF006F7-6C2D-4358-B56A-312585EB6EF5Q52096888-F043DC38-CCC5-43CE-B8DB-73A174AAB589Q54649970-D39BB661-4ABA-440E-81F6-EAEBE83580D3Q58291143-0CAB6A21-FF71-4EB0-8443-6FABA998A1D6Q90916644-93481B79-8A78-4830-BA6A-A2D6C67260EF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alberto Martire
@ast
Alberto Martire
@en
Alberto Martire
@es
Alberto Martire
@nl
type
label
Alberto Martire
@ast
Alberto Martire
@en
Alberto Martire
@es
Alberto Martire
@nl
prefLabel
Alberto Martire
@ast
Alberto Martire
@en
Alberto Martire
@es
Alberto Martire
@nl
P1053
G-1441-2016
P106
P21
P31
P3829
P496
0000-0003-0538-4704